Grommes C, DeAngelis LM. Primary CNS Lymphoma. J Clin Oncol. 2017;35:2410–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ney DE, Reiner AS, Panageas KS, Brown HS, DeAngelis LM, Abrey LE. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Cancer. 2010;116:4605–12.

PubMed  Article  Google Scholar 

Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, et al. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol. 2006;24:5711–5.

PubMed  Article  Google Scholar 

Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937–47.

PubMed  Article  Google Scholar 

Lymphoma & myeloma connect. COR2ED. [cited 2022 Mar 11]. Available from: https://lymphomamyelomaconnect.cor2ed.com/.

Yuan Y, Ding T, Wang S, Chen H, Mao Y, Chen T. Current and emerging therapies for primary central nervous system lymphoma. Biomark Res. 2021;9:32.

PubMed  PubMed Central  Article  Google Scholar 

Grommes C, Rubenstein JL, DeAngelis LM, Ferreri AJM, Batchelor TT. Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma. Neuro Oncol. 2019;21:296–305.

PubMed  Article  Google Scholar 

Osawa Y, Tanaka T, Semba RD, Fantoni G, Moaddel R, Candia J, et al. Proteins in the pathway from high red blood cell width distribution to all-cause mortality. EBioMedicine. 2022;76:103816.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52:86–105.

PubMed  Article  Google Scholar 

Kiefer CR, Snyder LM. Oxidation and erythrocyte senescence. Curr Opin Hematol. 2000;7:113–6.

CAS  PubMed  Article  Google Scholar 

Pan J, Borné Y, Engström G. The relationship between red cell distribution width and all-cause and cause-specific mortality in a general population. Sci Rep. 2019;9:16208.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Cheng K-C, Lin Y-M, Liu C-C, Wu K-L, Lee K-C. High red cell distribution width is associated with worse prognosis in early colorectal cancer after curative resection: a propensity-matched analysis. Cancers (Basel). 2022;14:945.

CAS  Article  Google Scholar 

Wu J, Yang Y, Cheng L, Wu J, Xi L, Ma Y, et al. GCdiscrimination: identification of gastric cancer based on a milliliter of blood. Brief Bioinform. 2021;22:536–44.

CAS  PubMed  Article  Google Scholar 

Yoo Y-C, Park S, Kim H-J, Jung H-E, Kim J-Y, Kim M-H. Preoperative routine laboratory markers for predicting postoperative recurrence and death in patients with breast cancer. J Clin Med. 2021;10:2610.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tao Y, Zhou Y, Chen H, Qin Y, He X, Liu P, et al. Prognostic role of red blood cell distribution width and platelet/lymphocyte ratio in early-stage classical Hodgkin lymphoma. Future Oncol. 2022;18(15):1817–27.

Herraez I, Bento L, Del Campo R, Sas A, Ramos R, Ibarra J, et al. Prognostic role of the red blood cell distribution width (RDW) in Hodgkin lymphoma. Cancers (Basel). 2020;12:E3262.

Article  CAS  Google Scholar 

Miao Y, Zhou X-H, Guo J-J, Sun Q, Shi K, Wu J-Z, et al. Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma. Cancer Med. 2019;8:2751–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bento L, Díaz-López A, Barranco G, Martín-Moreno AM, Baile M, Martín A, et al. New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish lymphoma group experience (GELTAMO). Br J Haematol. 2020;188:888–97.

CAS  PubMed  Article  Google Scholar 

Li M, Xia H, Zheng H, Li Y, Liu J, Hu L, et al. Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients. BMC Cancer. 2019;19:1084.

PubMed  PubMed Central  Article  Google Scholar 

Zhou S, Fang F, Chen H, Zhang W, Chen Y, Shi Y, et al. Prognostic significance of the red blood cell distribution width in diffuse large B-cell lymphoma patients. Oncotarget. 2017;8:40724–31.

PubMed  PubMed Central  Article  Google Scholar 

Lv C, Wang J, Zhou M, Xu J-Y, Chen B, Wan Y. Primary central nervous system lymphoma in the United States, 1975–2017. Ther Adv Hematol. 2022;13:20406207211066170.

Article  Google Scholar 

Chen Y, Huang J, He X, Gao Y, Mahara G, Lin Z, et al. A novel approach to determine two optimal cut-points of a continuous predictor with a U-shaped relationship to hazard ratio in survival data: simulation and application. BMC Med Res Methodol. 2019;19:96.

PubMed  PubMed Central  Article  Google Scholar 

Wieduwilt MJ, Valles F, Issa S, Behler CM, Hwang J, McDermott M, et al. Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Clin Cancer Res. 2012;18:1146–55.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Schorb E, Kasenda B, Atta J, Kaun S, Morgner A, Hess G, et al. Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation. Haematologica. 2013;98:765–70.

PubMed  PubMed Central  Article  Google Scholar 

Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.

CAS  PubMed  Article  Google Scholar 

Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–82.

CAS  PubMed  Article  Google Scholar 

Li Q, Ma J, Ma Y, Lin Z, Kang H, Chen B. Improvement of outcomes of an escalated high-dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study. Cancer Manag Res. 2021;13:6115–22.

PubMed  PubMed Central  Article  Google Scholar 

Wen S, Li C, Zhan X. Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine. EPMA J. 2022;13(1):9–37.

PubMed  Article  Google Scholar 

Bertele N, Karabatsiakis A, Buss C, Talmon A. How biomarker patterns can be utilized to identify individuals with a high disease burden: a bioinformatics approach towards predictive, preventive, and personalized (3P) medicine. EPMA J. 2021;12(4):507–16.

PubMed  PubMed Central  Article  Google Scholar 

Beltran BE, Paredes S, Castro D, Cotrina E, Sotomayor EM, Castillo JJ. High red cell distribution width is an adverse predictive and prognostic factor in patients with diffuse large B-cell lymphoma treated with chemoimmunotherapy. Clin Lymphoma Myeloma Leuk. 2019;19:e551–7.

PubMed  Article  Google Scholar 

Periša V, Zibar L, Sinčić-Petričević J, Knezović A, Periša I, Barbić J. Red blood cell distribution width as a simple negative prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective study. Croat Med J. 2015;56:334–43.

PubMed  PubMed Central  Article  Google Scholar 

Jahr G, Broi MD, Holte H, Beiske K, Meling TR. Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict overall survival in intracranial primary CNS lymphoma. Brain Behav. 2018;8:e00928.

PubMed  PubMed Central  Article  Google Scholar 

Cho H, Kim SH, Kim S-J, Chang JH, Yang W-I, Suh C-O, et al. Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma. Oncotarget. 2017;8:87317–28.

PubMed  PubMed Central  Article  Google Scholar 

Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009;169:515–23.

PubMed  PubMed Central  Article  Google Scholar 

Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44.

CAS  PubMed  Article  Google Scholar 

Drakopoulou M, Toutouzas K, Stefanadi E, Tsiamis E, Tousoulis D, Stefanadis C. Association of inflammatory markers with angiographic severity and extent of coronary artery disease. Atherosclerosis. 2009;206:335–9.

CAS  PubMed  Article  Google Scholar 

Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158:659–66.

PubMed  Article  Google Scholar 

Lhomme S, Abravanel F, Dubois M, Sandres-Saune K, Rostaing L, Kamar N, et al. Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients. J Virol. 2012;86:10006–14.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ferrara R, Mezquita L, Auclin E, Chaput N, Besse B. Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: does age really matter? Cancer Treat Rev. 2017;60:60–8.

CAS  PubMed  Article